SLC25A51 and neoplasm: Aspirin also potentiated protein hyperacetylation mediated by SLC25A51 KO or fludarabine treatment, significantly reducing tumor cell proliferation and colony formation, as well as inhibiting xenograft growth synergistically with fludarabine [194].